ArticleBMC rheumatology2022

Real world safety of CT-P10 (anti-CD 20 monoclonal antibodies biosimilar) in rheumatic and autoimmune diseases.

Wanruchada Katchamart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.